Antonini A - Search Results

1

Response to letter to the editor regarding "Does the 5-2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries".

Antonini A, Chaudhuri KR, Domingos J, Jimenez-Shahed J, Wright J, Yan CH, Alobaidi A, Bergmann L, Onuk K, Harmer L, Malaty IA. Antonini A, et al. BMC Neurol. 2024 Jul 30;24(1):266. doi: 10.1186/s12883-024-03691-3. BMC Neurol. 2024. PMID: 39080589 Free PMC article.

2

Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.

Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chaudhuri KR. Honig H, et al. Among authors: antonini a. Mov Disord. 2009 Jul 30;24(10):1468-74. doi: 10.1002/mds.22596. Mov Disord. 2009. PMID: 19425079 Clinical Trial.

3

Cognitive status of patients with Parkinson's disease and pathological gambling.

Siri C, Cilia R, De Gaspari D, Canesi M, Meucci N, Zecchinelli AL, Pezzoli G, Antonini A. Siri C, et al. Among authors: antonini a. J Neurol. 2010 Feb;257(2):247-52. doi: 10.1007/s00415-009-5301-5. Epub 2009 Sep 1. J Neurol. 2010. PMID: 19727901

4

Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease.

Antonini A, Chaudhuri KR, Martinez-Martin P, Odin P. Antonini A, et al. CNS Drugs. 2010 Feb;24(2):119-29. doi: 10.2165/11310940-000000000-00000. CNS Drugs. 2010. PMID: 20088619 Review.

5

A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation.

Antonini A, Isaias IU, Rodolfi G, Landi A, Natuzzi F, Siri C, Pezzoli G. Antonini A, et al. J Neurol. 2011 Apr;258(4):579-85. doi: 10.1007/s00415-010-5793-z. Epub 2010 Oct 23. J Neurol. 2011. PMID: 20972684 Clinical Trial.

6

Parkinson's disease: the non-motor issues.

Chaudhuri KR, Odin P, Antonini A, Martinez-Martin P. Chaudhuri KR, et al. Among authors: antonini a. Parkinsonism Relat Disord. 2011 Dec;17(10):717-23. doi: 10.1016/j.parkreldis.2011.02.018. Epub 2011 Jul 8. Parkinsonism Relat Disord. 2011. PMID: 21741874 Review.

7

Successful subthalamic stimulation in genetic Parkinson's disease caused by duplication of the α-synuclein gene.

Antonini A, Pilleri M, Padoan A, Landi A, Ferla S, Biundo R, D'Avella D. Antonini A, et al. J Neurol. 2012 Jan;259(1):165-7. doi: 10.1007/s00415-011-6162-2. Epub 2011 Jul 15. J Neurol. 2012. PMID: 21761143

8

Movement disorders: towards new therapies in Parkinson's disease.

Antonini A. Antonini A. Lancet Neurol. 2012 Jan;11(1):7-8. doi: 10.1016/S1474-4422(11)70284-8. Lancet Neurol. 2012. PMID: 22172611 No abstract available.

9

Gender-related differences in the burden of non-motor symptoms in Parkinson's disease.

Martinez-Martin P, Falup Pecurariu C, Odin P, van Hilten JJ, Antonini A, Rojo-Abuin JM, Borges V, Trenkwalder C, Aarsland D, Brooks DJ, Ray Chaudhuri K. Martinez-Martin P, et al. Among authors: antonini a. J Neurol. 2012 Aug;259(8):1639-47. doi: 10.1007/s00415-011-6392-3. Epub 2012 Jan 12. J Neurol. 2012. PMID: 22237822

10

Intrajejunal levodopa versus conventional therapy in Parkinson disease: motor and nonmotor effects.

Reddy P, Martinez-Martin P, Rizos A, Martin A, Faye GC, Forgacs I, Odin P, Antonini A, Chaudhuri KR. Reddy P, et al. Among authors: antonini a. Clin Neuropharmacol. 2012 Sep-Oct;35(5):205-7. doi: 10.1097/WNF.0b013e3182613dea. Clin Neuropharmacol. 2012. PMID: 22821063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters